Accenture plc's recent price correction is an overreaction to a few temporary macroeconomic headwinds. These headwinds include the DOGE initiatives and trade disputes, but are temporary in my view. Fundamentally, I see a highly profitable business with promising growth potential (especially AI-related) at a discounted price.
Whatever Happened to Pandemic Stocks? Some Are Showing Life Again — Positive
PTON SHOP ZM Zacks Investment Research — May 23, 2025A handful of stocks benefited massively during the pandemic. It was an interesting time to be an investor, to say the least, and those who targeted the stay-at-home stocks were rewarded handsomely with considerable gains.
Ellerbroek: Tariffs Risk to A.I. Growth, NVDA, GOOGL & MSFT Top Picks — Neutral
GOOG GOOGL MSFT NVDA Schwab Network — May 23, 2025"The less we're talking about tariffs, the more optimistic I am," argues Jed Ellerbroek. He sees promise in A.I.
Dagen McDowell advises Apple's Tim Cook to ‘play better ball' with Trump amid threat — Negative
AAPL Fox Business — May 23, 2025'The Big Money Show' panel discusses President Donald Trump's tariff threat directed at Apple and European Union trade talks.
Class Action Lawsuit Filed Against Solaris Energy Infrastructure, Inc. (SEI) - Recover Losses - Contact Levi & Korsinsky Before May 27, 2025 — Neutral
SEI Accesswire — May 23, 2025NEW YORK, NY / ACCESS Newswire / May 23, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/solaris-energy-infrastructure-inc-lawsuit-submission-form?prid=150019&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.
Reasons to Retain Charles River Stock in Your Portfolio for Now — Positive
CRAI Zacks Investment Research — May 23, 2025CRAI stock rises 16% in a month, backed by rising earnings, growing dividends, and steady buybacks despite a tight labor market and liquidity concerns.
Here's Why You Should Retain BXP Stock in Your Portfolio Now — Positive
BXP Zacks Investment Research — May 23, 2025BXP is set to gain from a premium office portfolio, a diverse tenant base, strong lab asset demand and a healthy balance sheet despite high supply.
ETFs to Capitalize on Trump's Orders to Spur Nuclear Energy — Positive
NLR URA URNJ URNM Zacks Investment Research — May 23, 2025Trump's executive orders to boost U.S. nuclear energy spark a rally in ETFs like NLR, URAN, URA, URNM and URNJ.
Flanigan's Stock Gains Post Q2 Earnings, Revenues and Profit Improve — Positive
BDL Zacks Investment Research — May 23, 2025BDL reports strong second-quarter fiscal 2025 earnings with revenue and profit growth fueled by higher menu prices, increased store traffic and a new restaurant opening.
Are You Looking for a Top Momentum Pick? Why Centrus Energy Corp. (LEU) is a Great Choice — Positive
LEU Zacks Investment Research — May 23, 2025Does Centrus Energy Corp. (LEU) have what it takes to be a top stock pick for momentum investors? Let's find out.
SkyWest (SKYW) is a Great Momentum Stock: Should You Buy? — Positive
SKYW Zacks Investment Research — May 23, 2025Does SkyWest (SKYW) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Allegheny Technologies (ATI) a Strong Momentum Stock: Buy Now? — Positive
ATI Zacks Investment Research — May 23, 2025Does Allegheny Technologies (ATI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Perdoceo Education (PRDO) is a Great Momentum Stock: Should You Buy? — Positive
PRDO Zacks Investment Research — May 23, 2025Does Perdoceo Education (PRDO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Allient (ALNT) is a Great Momentum Stock: Should You Buy? — Positive
ALNT Zacks Investment Research — May 23, 2025Does Allient (ALNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know — Positive
ATAI Zacks Investment Research — May 23, 2025Does atai Life Sciences N.V. (ATAI) have what it takes to be a top stock pick for momentum investors?
Seres Therapeutics (MCRB) Upgraded to Buy: What Does It Mean for the Stock? — Positive
MCRB Zacks Investment Research — May 23, 2025Seres Therapeutics (MCRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Domo (DOMO) is a Great Momentum Stock: Should You Buy? — Positive
DOMO Zacks Investment Research — May 23, 2025Does Domo (DOMO) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Relay Therapeutics (RLAY) a New Buy Stock — Positive
RLAY Zacks Investment Research — May 23, 2025Relay Therapeutics (RLAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Fathom Holdings (FTHM) Moves to Buy: Rationale Behind the Upgrade — Positive
FTHM Zacks Investment Research — May 23, 2025Fathom Holdings (FTHM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Exelixis (EXEL) Upgraded to Buy: What Does It Mean for the Stock? — Positive
EXEL Zacks Investment Research — May 23, 2025Exelixis (EXEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
